OIG Finds Medicare Part D Still Spending Millions for Hospice Drugs

Over recent years the Department of Health & Human Services Office of the Inspector General (OIG) and others have conducted analyses of spending outside of hospice while patients are on service and determined that Medicare may be paying separately for care (including prescription drugs under Part D) that should be the responsibility of the hospice. …

Drug Shortage Crisis Concerns Hospice, Draws Bipartisan Interest

The Food and Drug Administration identified 39 new drug and biological product shortages in 2017 and multiple ongoing shortages from previous years, a sharp increase from 2016, according to the FDA’s most recent annual report on the issue. The main problems were caused by a major manufacturer shutting down a production facility, and devastation caused…